Bone morphogenetic protein receptor signaling is necessary for normal murine postnatal bone formation. - Wikidata - thesis-toulmin - TriplyDB

Bone morphogenetic protein receptor signaling is necessary for normal murine postnatal bone formation.

Bone morphogenetic protein receptor signaling is necessary for normal murine postnatal bone formation.

http://www.wikidata.org/entity/Q36325743

about

High-density association study of 383 candidate genes for volumetric BMD at the femoral neck and lumbar spine among older men The biological function of type I receptors of bone morphogenetic protein in bone Living biointerfaces based on non-pathogenic bacteria support stem cell differentiation Bone morphogenetic protein type IA receptor signaling regulates postnatal osteoblast function and bone remodeling Filamin B mutations cause chondrocyte defects in skeletal development c-Abl promotes osteoblast expansion by differentially regulating canonical and non-canonical BMP pathways and p16INK4a expression Involvement of endogenous bone morphogenetic protein (BMP) 2 and BMP6 in bone formation Cthrc1 is a positive regulator of osteoblastic bone formation Ubiquitin ligase Smurf1 controls osteoblast activity and bone homeostasis by targeting MEKK2 for degradation BMP type I receptor ALK2 is essential for proper patterning at late gastrulation during mouse embryogenesis Mammalian twisted gastrulation is essential for skeleto-lymphogenesis The zinc finger transcription factor Gli2 mediates bone morphogenetic protein 2 expression in osteoblasts in response to hedgehog signaling Beta-catenin and BMP-2 synergize to promote osteoblast differentiation and new bone formation.Bmp2 in osteoblasts of periosteum and trabecular bone links bone formation to vascularization and mesenchymal stem cells.Dmp1-deficient mice display severe defects in cartilage formation responsible for a chondrodysplasia-like phenotype Matrix extracellular phosphoglycoprotein (MEPE) is a new bone renal hormone and vascularization modulator.BMP-2 modulates beta-catenin signaling through stimulation of Lrp5 expression and inhibition of beta-TrCP expression in osteoblasts.Transcriptional regulation of BMP2 expression by the PTH-CREB signaling pathway in osteoblasts.TGFbeta/BMP type I receptors ALK1 and ALK2 are essential for BMP9-induced osteogenic signaling in mesenchymal stem cells.Conditional ablation of Pten in osteoprogenitors stimulates FGF signaling Smad1 plays an essential role in bone development and postnatal bone formation.Osthole stimulates osteoblast differentiation and bone formation by activation of beta-catenin-BMP signaling.Loss of BMPR2 leads to high bone mass due to increased osteoblast activity Age dependent regulation of bone-mass and renal function by the MEPE ASARM-motif Modulation of Bone Morphogenetic Protein (BMP) 2 gene expression by Sp1 transcription factors.Chondrocytes-Specific Expression of Osteoprotegerin Modulates Osteoclast Formation in Metaphyseal Bone DNA methylation Landscape of body size variation in sheep The BMP signaling and in vivo bone formation 2,4,5-Trimethoxyldalbergiquinol promotes osteoblastic differentiation and mineralization via the BMP and Wnt/β-catenin pathway.Dose-dependent inhibitory effects of zoledronic acid on osteoblast viability and function in vitro The soluble form of BMPRIB is a novel therapeutic candidate for treating bone related disorders.Advances in dental implant materials and tissue regeneration.BMP signaling in mesenchymal stem cell differentiation and bone formation.Function of BMPs and BMP antagonists in adult bone.MicroRNA variants as genetic determinants of bone mass Deubiquitinase MYSM1 Is Essential for Normal Bone Formation and Mesenchymal Stem Cell Differentiation.Differences in gene expression between the otic capsule and other bones.Bone morphogenetic protein 2-induced human dental pulp cell differentiation involves p38 mitogen-activated protein kinase-activated canonical WNT pathway Functional redundancy of type II BMP receptor and type IIB activin receptor in BMP2-induced osteoblast differentiation Overexpression of H1 calponin in osteoblast lineage cells leads to a decrease in bone mass by disrupting osteoblast function and promoting osteoclast formation.

P2860

Q24643761-313B0734-AFC2-4D44-A85F-AD3A95600B8C Q26752839-7D44DF05-93FD-4FFD-8C30-3D5C869C0DE0 Q27343017-FEC8DDBF-74A6-437C-BAC6-1C6AE79CB6F2 Q28257036-824CFC95-9D15-45CE-A245-406F78F82882 Q28302896-76D4568F-898D-4B8C-AAAA-3E7D09BA360A Q28504995-360E9B28-BE19-4F97-9A22-4FA566BB0130 Q28511390-0F8F9A27-91A1-4E48-93E6-F71E9A189886 Q28511903-D125B7FB-2E59-4F24-80B2-F624793B3B7D Q28513591-60FB9C78-6A45-403F-BB72-47BC7665A7E9 Q28586330-F774D03E-1AF5-4CDC-8587-89B0C2D69C08 Q28589896-0927B568-DC18-433C-B306-E449305D2B76 Q28593888-C911CD37-E8AA-453E-A187-65E98CF16038 Q30440191-4FE76895-73FC-45E5-BBFA-08224CB37233 Q30544691-16DFE3FC-33FC-4050-8B2A-49892CA2770D Q33209762-E9D7D79C-79C9-4CDB-97E7-1F9B24C2D0A5 Q33643995-858D452C-D4F4-4545-9314-42096E6E0225 Q33723850-89118DC6-9F1D-4536-A110-900535CB65EE Q33939715-D5825503-9CA5-4622-BB1A-5A5DB3A04F10 Q34121672-96819708-3FAA-45F1-9394-F6CB9841CEE0 Q34632753-93CD2B64-AF91-4BC8-97FA-5F847D8B94E9 Q35041301-D8B93686-1B85-416E-933D-68C1865242CC Q35155501-3A1CA2DA-BED7-4668-8D26-39E333687962 Q35233209-C7C3F9C1-363A-4623-8992-292A0A74EFC0 Q35850452-9DAF25D3-3945-4306-AC0B-8C1C91D77519 Q35915965-12E043C8-D8E6-41AA-A03A-C448847C6375 Q36017881-0DA487B5-71FE-45F7-9426-FCA2F22C10FC Q36168356-D0A93D38-F430-44CE-AA4B-D4BBDE00EC7B Q36242266-0F5FB08D-FD36-4F10-9856-485202A6B402 Q36293864-1F612D8C-926B-4120-83A5-41F091CFB24D Q36390242-A8513E38-E388-4782-A57A-F5FBB14030AE Q36432535-43422D3E-6987-4F64-88DA-181D22CF8F62 Q36474289-5676021F-D97E-4E1E-9BCA-8D694D1A56E7 Q36498604-A56706E1-C650-4D21-A2E4-9797C74D50F7 Q36532502-284ADA22-7EFD-438D-988F-2E763E5E74A1 Q36586312-33A38F80-46DE-4E30-9FF6-0073064BB14E Q36621378-966AD990-649D-4B68-B536-4DB0032B67B3 Q36652405-720144AD-AC2B-41C2-AB78-D0126E40D085 Q36756112-6744E95A-C65F-49C5-AB75-8AC6FC9EF839 Q36934968-480BC882-57D6-4019-99B3-BC3A5A2776A7 Q37026949-28CEA9E2-9739-4535-9ED2-5394D55A853A

P2860

Bone morphogenetic protein receptor signaling is necessary for normal murine postnatal bone formation.

http://www.wikidata.org/entity/Q36325743

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh

2002年學術文章

@zh-hant

name

Bone morphogenetic protein rec ...... rine postnatal bone formation.

@ast

Bone morphogenetic protein rec ...... rine postnatal bone formation.

@en

type

label

Bone morphogenetic protein rec ...... rine postnatal bone formation.

@ast

Bone morphogenetic protein rec ...... rine postnatal bone formation.

@en

prefLabel

Bone morphogenetic protein rec ...... rine postnatal bone formation.

@ast

Bone morphogenetic protein rec ...... rine postnatal bone formation.

@en

P1433

Q36325743-2A32BDF4-EB6F-4174-8601-20CF08009900

P1476

Q36325743-A5032CBB-4519-45A5-9BBC-57B09BDE42D2

P2093

Q36325743-23E3EECB-1685-46A3-922F-4DF976D0A12C

Q36325743-6D597BE1-D0AD-4A98-B3B6-9EA6CDF7D73D

Q36325743-9F163A1B-EAD8-4785-BE52-8327ECA0AE78

Q36325743-BA475936-B500-409B-B082-FC2E56D350B3

Q36325743-CAD9AA8F-FB89-4D9D-A488-C84382DE1888

Q36325743-DBA0E179-EC88-421C-98D0-56E5CF8C2191

Q36325743-FF19C6BD-D427-4D95-A07F-42D22197BAE7

P2860

Q36325743-078D315A-AD13-4AE7-A13A-88C9804F7A2C

Q36325743-0D99B34C-C2ED-48BF-8079-ECDA697D2E28

Q36325743-0F58F1EA-4F7B-4F5D-800A-53A10BEF0252

Q36325743-11937A03-9EAF-4B9C-BCC0-5B2D48B11BD4

Q36325743-12697394-E759-4A2B-BAE0-0116DA4104A3

Q36325743-14261CAA-3B7C-439E-9BE1-4ABF9D647D41

Q36325743-16C187DB-2E64-4372-9DCC-237CC65A802C

Q36325743-1CE94BD5-9EC3-4BF0-86F6-9FF5E5267FA4

Q36325743-22275F0E-04B1-445B-9C75-A345AE4F21DA

Q36325743-2BB379E2-C865-4CF1-8859-03ED6AC63B0F

P304

Q36325743-4E6BBC73-BB09-41BA-8929-C11353AA2FA9

P31

Q36325743-45C93DC8-C468-409B-899B-B034C0D3BAB6

P356

Q36325743-FE56150D-76B0-43E2-878D-6A7FC359C5B9

P407

Q36325743-2EE96643-B676-4286-AAD5-5484EEBEFD66

P433

Q36325743-A842BA04-684A-4BE6-86AF-0239B00E095D

P478

Q36325743-CD45AC31-803C-49EF-9546-EF09E3EBA0FD

P577

Q36325743-52B7428E-4317-475E-92DF-9B629990D9C4

P5875

Q36325743-B7A5BD4D-2E7F-4EE8-A066-C75CEE60C843

P698

Q36325743-084FBB64-5DA8-46D3-A466-20754B7BBD8B

P921

Q36325743-93256E59-FD0F-4718-A515-FD24FFAC7880

P932

Q36325743-199F378E-F6EB-4702-9F09-F3794E3C86B0

P356

P1433

Journal of Cell Biology

P1476

Bone morphogenetic protein rec ...... rine postnatal bone formation.

@en

P2093

Di Chen

http://www.w3.org/2001/XMLSchema#string

Diane Horn

http://www.w3.org/2001/XMLSchema#string

Gregory R Mundy

http://www.w3.org/2001/XMLSchema#string

Ming Zhao

http://www.w3.org/2001/XMLSchema#string

Riko Nishimura

http://www.w3.org/2001/XMLSchema#string

Stephen E Harris

http://www.w3.org/2001/XMLSchema#string

Zhaopo Geng

http://www.w3.org/2001/XMLSchema#string

P2860

Novel regulators of bone formation: molecular clones and activities

A mammalian serine/threonine kinase receptor specifically binds BMP-2 and BMP-4

MADR1, a MAD-related protein that functions in BMP2 signaling pathways

Recombinant Vgr-1/BMP-6-expressing tumors induce fibrosis and endochondral bone formation in vivo

A human chondrodysplasia due to a mutation in a TGF-beta superfamily member

Cartilage-derived morphogenetic proteins. New members of the transforming growth factor-beta superfamily predominantly expressed in long bones during human embryonic development

Human type II receptor for bone morphogenic proteins (BMPs): extension of the two-kinase receptor model to the BMPs

Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development

Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation

Disruption of human limb morphogenesis by a dominant negative mutation in CDMP1

P304

1049-1060

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1083/JCB.200109012

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

157

http://www.w3.org/2001/XMLSchema#string

P577

2002-06-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11316170

http://www.w3.org/2001/XMLSchema#string

P698

12058020

http://www.w3.org/2001/XMLSchema#string

P921

P932

2174055

http://www.w3.org/2001/XMLSchema#string